Bipolar disorder: assessment and management (NICE guideline CG185)
This guideline cites 4 of the 62 landmark trials in our Psychiatry & psychotherapy register.
- Issued by
- NICE
- Year
- 2014
- Source
- National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. NICE guideline [CG185]. Published 24 September 2014; last updated 2 September 2025.
CG185 keeps lithium as the first-line long-term treatment for bipolar disorder — a position it has held through the 2025 update — with valproate avoided in women of childbearing potential and antidepressant monotherapy discouraged. Alongside the pharmacology it recommends a structured psychological intervention designed for bipolar disorder for people in remission or with mild depressive symptoms. The register trials below cover that psychosocial arm: family-focused therapy, CBT as an adjunct, and intensive psychotherapy for bipolar depression.
Family-focused therapy1
- 2003Miklowitz FFT CorePsychiatry · Bipolar · Family-focused therapyIn 101 adults with bipolar I after a recent mood episode, 21 sessions of family-focused therapy + mood stabilisers reduced 2-year relapse compared with crisis management + mood stabilisers.35% vs 54%Read →
CBT as an adjunct to pharmacotherapy2
- 2006Scott CBTPsychiatry · Bipolar · CBT add-onIn 253 bipolar I/II patients in routine care, 22 sessions of cognitive therapy + TAU did not reduce recurrence overall compared with treatment as usual, but helped patients with fewer prior episodes.Read →
- 2003Lam CBTPsychiatry · Bipolar · CBT add-onIn 103 euthymic bipolar I patients, 14 sessions of cognitive therapy + treatment as usual reduced 12-month relapse compared with treatment as usual alone.44% vs 75%Read →
Intensive psychotherapy for bipolar depression1
- 2007STEP-BD PsyPsychiatry · Bipolar · Intensive psychotherapyIn 293 bipolar I/II patients in a depressive episode, intensive psychotherapy (FFT, CBT or IPSRT) improved 12-month recovery compared with 3-session collaborative care.HR 1.47Read →
Cited landmark trials not yet in the register4
Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.
- 2010BALANCE
Lithium, valproate or both for relapse prevention in bipolar I disorder.
- 2003Colom psychoeducation
Group psychoeducation prevented recurrence in remitted bipolar disorder.
- 2007STEP-BD (antidepressant adjunct)
Adjunctive antidepressants added no benefit over mood stabiliser alone.
- 2011Cipriani antimanic NMA
Comparative efficacy of antimanic drugs in acute mania.
Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.